Michael B. Mason - 10 Feb 2023 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role: EVP & Pres., Lilly Diabetes
Signature: /s/ Jonathan Groff for Michael B. Mason, pursuant to authorization on file
Issuer symbol: LLY
Transactions as of: 10 Feb 2023
Net transactions value: +$2,768,898
Form type: 4
Filing time: 14 Feb 2023, 15:49:07 UTC
Previous filing: 03 Feb 2023
Next filing: 02 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LLY	Common Stock	Award	$2,768,898	+8,023	+26%	$345.12	39,284	10 Feb 2023	Direct
holding	LLY	Common Stock						957	10 Feb 2023	401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LLY	Restricted Stock Unit	Award	$0	+3,490		$0.000000	3,490	10 Feb 2023	Common Stock	3,490		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.